Gillian Duchesne

Optimal Planning Target Volume for Stage I Testicular Seminoma: A Medical Research Council Randomized Trial

Sophie D. Fosså, A. Horwich, JM Russell et al. · Journal of Clinical Oncology · 1999 · 385 citations

Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial

James W. Denham, Allison Steigler, David S. Lamb et al. · The Lancet Oncology · 2005 · 376 citations

Urology, Radiation Medicine, Radiation Therapy +6

Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial

Andrew Kneebone, Carol Fraser‐Browne, Gillian Duchesne et al. · The Lancet Oncology · 2020 · 349 citations · Full text

Surgical Oncology, Urology, Radiation Therapy +10

A dose-controlled study of 153Sm-Ethylenediaminetetramethylenephosphonate (EDTMP) in the treatment of patients with painful bone metastase

I. Resche, J.F. Chatal, A Pecking et al. · European Journal of Cancer · 1997 · 253 citations

Bone Disease, Medicine, Spinal Oncology +6

Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial

Gillian Duchesne, Henry H. Woo, Julie K. Bassett et al. · The Lancet Oncology · 2016 · 213 citations

Androgen-deprivation Therapy, Urology, Genitourinary Cancer +7